Evidence of potentially unrelated AmpC beta-lactamase producing Enterobacteriaceae from cattle, cattle products and hospital environments commonly harboring the blaACC resistance determinant
Author(s) -
Keduetswe Matloko,
Justine Fri,
Tshepiso Pleasure Ateba,
Lesego G. Molale-Tom,
Collins Njie Ateba
Publication year - 2021
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0253647
Subject(s) - microbiology and biotechnology , cefoxitin , biology , shigella , amikacin , enterobacteriaceae , macconkey agar , cefepime , piperacillin , beta lactamase , klebsiella pneumoniae , ciprofloxacin , antibiotic resistance , veterinary medicine , antibiotics , escherichia coli , imipenem , agar , bacteria , salmonella , medicine , genetics , gene , pseudomonas aeruginosa , staphylococcus aureus
The occurrence and genetic relatedness of AmpC beta-lactamase producing Enterobacteriaceae isolated from clinical environments, groundwater, beef, human and cattle faeces were investigated. One hundred seventy-seven (177) samples were collected and cultured on MacConkey agar. A total of 203 non-repetitive isolates were characterised using genus/species-specific PCRs and the identified isolates were subjected to antibiotic susceptibility testing. The production of AmpC beta-lactamases was evaluated using cefoxitin disc, confirmed by the D96C detection test and their encoding genes detected by PCR. The D64C extended-spectrum beta-lactamases (ESBL) test was also performed to appraise ESBLs/AmpC co-production. The genetic fingerprints of AmpC beta-lactamase producers were determined by ERIC-PCR. A total of 116 isolates were identified as E . coli ( n = 65), Shigella spp. ( n = 36) and Klebsiella pneumoniae ( n = 15). Ciprofloxacin resistance (44.4–55.4%) was the most frequent and resistance against the Cephem antibiotics ranged from 15–43.1% for E . coli , 25–36.1% for Shigella spp., and 20–40% for K . pneumoniae . On the other hand, these bacteria strains were most sensitive to Amikacin (0%), Meropenem (2.8%) and Piperacillin-Tazobactam (6.7%) respectively. Nineteen (16.4%) isolates comprising 16 E . coli and 3 Shigella spp. were confirmed as AmpC beta-lactamase producers. However, only E . coli isolates possessed the corresponding resistance determinants: bla ACC (73.7%, n = 14), bla CIT (26%, n = 5), bla DHA (11%, n = 2) and bla FOX (16%, n = 3). Thirty-four (27.3%) Enterobacteriaceae strains were confirmed as ESBL producers and a large proportion (79.4%, n = 27) harboured the bla TEM gene, however, only two were ESBLs/AmpC co-producers. Genetic fingerprinting of the AmpC beta-lactamase-producing E . coli isolates revealed low similarity between isolates. In conclusion, the findings indicate the presence of AmpC beta-lactamase-producing Enterobacteriaceae from cattle, beef products and hospital environments that commonly harbour the associated resistance determinants especially the bla ACC gene, nonetheless, there is limited possible cross-contamination between these environments.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom